Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

GT Biopharma (GTBP) Other Non Operating Income (2016 - 2021)

GT Biopharma (GTBP) has disclosed Other Non Operating Income for 10 consecutive years, with $179000.0 as the latest value for Q4 2021.

  • On a quarterly basis, Other Non Operating Income changed N/A to $179000.0 in Q4 2021 year-over-year; TTM through Dec 2021 was -$781000.0, a N/A change, with the full-year FY2025 number at $156000.0, changed N/A from a year prior.
  • Other Non Operating Income was $179000.0 for Q4 2021 at GT Biopharma, up from -$501000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.7 million in Q1 2017 to a low of -$1.5 million in Q3 2017.
  • A 3-year average of $134375.0 and a median of -$173000.0 in 2017 define the central range for Other Non Operating Income.
  • Biggest YoY gain for Other Non Operating Income was 86.44% in 2017; the steepest drop was 432.8% in 2017.
  • GT Biopharma's Other Non Operating Income stood at -$1.5 million in 2017, then surged by 164.16% to $931000.0 in 2020, then plummeted by 80.77% to $179000.0 in 2021.
  • Per Business Quant, the three most recent readings for GTBP's Other Non Operating Income are $179000.0 (Q4 2021), -$501000.0 (Q3 2021), and -$480000.0 (Q2 2021).